Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug

• Main Authors: Tham, L.-S., Lee, H.-S., Wang, L., Yong, W.-P., Fan, L., Ong, A.-B., Sukri, N., Soo, R., Lee, S.-C., Goh, B.-C.
• Other Authors: PHARMACY
• Format: Article
• Published: 2014
• Subjects: CYP3A; Ketoconazole; Limited sampling strategy; Midazolam
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/106101
• Institution: National University of Singapore

10.1097/01.ftd.0000194497.55269.d9